NFκB/p53 crosstalk—a promising new therapeutic target

The hallmarks of cancer

Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · see citing works

Immunity, Inflammation, and Cancer

Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755 · see citing works

The basics of epithelial-mesenchymal transition

Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196 · see citing works

Epithelial-Mesenchymal Transitions in Development and Disease

Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931 · see citing works

Shared Principles in NF-κB Signaling

Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,814 · see citing works

The metabolism of tumors in the body

Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416 · see citing works

Cancer Metastasis: Building a Framework

Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,230 · see citing works

Nuclear factor-κB in cancer development and progression

Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519 · see citing works

Blinded by the Light: The Growing Complexity of p53

Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163 · see citing works

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,882 · see citing works

p21 in cancer: Intricate networks and multiple activities

Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712 · see citing works

Integrating cell-signalling pathways with NF-κB and IKK function

Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350 · see citing works

NF-κB functions as a tumour promoter in inflammation-associated cancer

Pikarsky, E., Porat, R., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,295 · see citing works

Curcumin as “Curecumin”: From kitchen to clinic

Goel, A., Kunnumakkara, A. B., & Aggarwal, B. B. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.016 · Cited by 2,220 · see citing works

TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis

Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019 · see citing works

The p53 pathway: positive and negative feedback loops

Harris, S. L., & Levine, A. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208615 · Cited by 1,967 · see citing works

p53 Regulates Mitochondrial Respiration

Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650 · see citing works

Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway

Senftleben, U., Cao, Y., Xiao, G., Greten, F. R., Krähn, G. M., Bonizzi, G., Chen, Y., Hu, Y., Fong, A., Sun, S., et al. (2001) · Science · doi:10.1126/science.1062677 · Cited by 1,361 · see citing works

Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

Toledo, F., & Wahl, G. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2012 · Cited by 1,286 · see citing works

Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM

Hickson, I., Zhao, Y., Richardson, C. J., Green, S. J., Martin, N. M. B., Orr, A. I., Reaper, P. M., Jackson, S. P., Curtin, N. J., & Smith, G. C. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2727 · Cited by 1,220 · see citing works

Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer

Grivennikov, S. I., & Karin, M. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.005 · Cited by 1,160 · see citing works

Hallmarks of cancer: Interactions with the tumor stroma

Pietras, K., & Östman, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.045 · Cited by 1,137 · see citing works

When mutants gain new powers: News from the mutant p53 field

Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132 · see citing works

Single-strand break repair and genetic disease

Caldecott, K. W. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2380 · Cited by 1,034 · see citing works

p53 and metabolism

Vousden, K. H., & Ryan, K. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2715 · Cited by 959 · see citing works

TP53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes

Petitjean, A., Achatz, M. I. W., Borresen-Dale, A. L., Hainaut, P., & Olivier, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210302 · Cited by 884 · see citing works

Awakening guardian angels: drugging the p53 pathway

Brown, C. J., Lain, S., Verma, C. S., Fersht, A. R., & Lane, D. P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2763 · Cited by 881 · see citing works

NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100

Xiao, G., Harhaj, E. W., & Sun, S. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00187-3 · Cited by 836 · see citing works

TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion

Wu, Y., & Zhou, B. P. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605530 · Cited by 801 · see citing works

Mutant p53 drives invasion by promoting integrin recycling

Muller, P. A. J., Caswell, P. T., Doyle, B., Iwanicki, M. P., Tan, E. H., Karim, S., Lukashchuk, N., Gillespie, D. A., Ludwig, R. L., Gosselin, P., et al. (2009) · Cell · doi:10.1016/j.cell.2009.11.026 · Cited by 796 · see citing works

Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53

Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J., & Murphy, M. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106643200 · Cited by 794 · see citing works

Mutant p53 Gain-of-Function in CancerPreprint

Oren, M., & Rotter, V. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001107 · Cited by 753 · see citing works

Role of NF-κB in p53-mediated programmed cell death

Ryan, K. M., Ernst, M. K., Rice, N. R., & Vousden, K. H. (2000) · Nature · doi:10.1038/35009130 · Cited by 735 · see citing works

The Tumor Suppressor p53 Down-Regulates Glucose Transporters GLUT1 and GLUT4 Gene Expression

Bar‐Yoseph, F., Armoni, M., & Karnieli, E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0846 · Cited by 728 · see citing works

Maximizing mouse cancer models

Frese, K. K., & Tuveson, D. A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2192 · Cited by 711 · see citing works

Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors

Lee, H., Herrmann, A., Deng, J.-H., Kujawski, M., Niu, G., Li, Z., Forman, S., Jove, R., Pardoll, D. M., & Yu, H. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.02.015 · Cited by 683 · see citing works

Transient cyclical methylation of promoter DNA

Kangaspeska, S., Stride, B. D., Métivier, R., Polycarpou-Schwarz, M., Ibberson, D., Carmouche, R. P., Beneš, V., Gannon, F., & Reid, G. (2008) · Nature · doi:10.1038/nature06640 · Cited by 682 · see citing works

Acetylation of non-histone proteins modulates cellular signalling at multiple levels

Spange, S., Wagner, T., Heinzel, T., & Krämer, O. H. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.08.027 · Cited by 665 · see citing works

IκB kinase complexes: gateways to NF-κB activation and transcription

Scheidereit, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209934 · Cited by 652 · see citing works

NF-κB and cancer — identifying targets and mechanisms

Naugler, W. E., & Karin, M. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.020 · Cited by 636 · see citing works

p53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation

Kawauchi, K., Araki, K., Tobiume, K., & Tanaka, N. (2008) · Nature Cell Biology · doi:10.1038/ncb1724 · Cited by 635 · see citing works

Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction to Reactivate p53 Function: A Novel Approach for Cancer Therapy

Shangary, S., & Wang, S. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094723 · Cited by 623 · see citing works

Functions of NF-κB1 and NF-κB2 in immune cell biology

Beinke, S., & Ley, S. C. (2004) · Biochemical Journal · doi:10.1042/bj20040544 · Cited by 611 · see citing works

Inhibitors of NF-κB signaling: 785 and counting

Gilmore, T. D., & Herscovitch, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209982 · Cited by 571 · see citing works

Transcriptional Regulation by P53

Beckerman, R., & Prives, C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000935 · Cited by 569 · see citing works

Sequential Modification of NEMO/IKKγ by SUMO-1 and Ubiquitin Mediates NF-κB Activation by Genotoxic Stress

Huang, T. T., Wuerzberger‐Davis, S. M., Wu, Z., & Miyamoto, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00895-x · Cited by 560 · see citing works

Molecular Linkage Between the Kinase ATM and NF-κB Signaling in Response to Genotoxic Stimuli

Wu, Z., Shi, Y., Tibbetts, R. S., & Miyamoto, S. (2006) · Science · doi:10.1126/science.1121513 · Cited by 515 · see citing works

Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma

Meylan, E., Dooley, A. L., Feldser, D. M., Shen, L., Turk, E., Ouyang, C., & Jacks, T. (2009) · Nature · doi:10.1038/nature08462 · Cited by 514 · see citing works

A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells

Song, H., Wang, R., Wang, S., & Lin, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409894102 · Cited by 504 · see citing works

The p53 orchestra: Mdm2 and Mdmx set the tone

Wade, M., Wang, Y. V., & Wahl, G. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.009 · Cited by 450 · see citing works

Inhibitors of Ubiquitin-Activating Enzyme (E1), a New Class of Potential Cancer Therapeutics

Yang, Y., Kitagaki, J., Dai, R., Tsai, Y. C., Lorick, K. L., Ludwig, R. L., Pierre, S. A., Jensen, J. P., Davydov, I. V., Oberoi, P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0568 · Cited by 442 · see citing works

Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation

He, G., Yu, G.-Y., Temkin, V., Ogata, H., Kuntzen, C., Sakurai, T., Sieghart, W., Peck-Radosavljevic, M., Leffert, H. L., & Karin, M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.048 · Cited by 427 · see citing works

Targeting transcription factor NF-κB to overcome chemoresistance and radioresistance in cancer therapy

Li, F., & Sethi, G. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.002 · Cited by 402 · see citing works

IKK/NF‐κB and STAT3 pathways: central signalling hubs in inflammation‐mediated tumour promotion and metastasis

Bollrath, J., & Greten, F. R. (2009) · EMBO Reports · doi:10.1038/embor.2009.243 · Cited by 381 · see citing works

Transcription-independent p53 apoptosis: an alternative route to death

Speidel, D. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.10.002 · Cited by 356 · see citing works

Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers

Bonizzi, G., Bébien, M., Otero, D. C., Johnson-Vroom, K. E., Cao, Y., Vu, D., Jegga, A. G., Aronow, B. J., Ghosh, G., Rickert, R. C., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600391 · Cited by 338 · see citing works

Signals from within: the DNA-damage-induced NF-κB response

Janssens, S., & Tschopp, J. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401843 · Cited by 321 · see citing works

PIDD Mediates NF-κB Activation in Response to DNA Damage

Janssens, S., Tinel, A., Lippens, S., & Tschopp, J. (2005) · Cell · doi:10.1016/j.cell.2005.09.036 · Cited by 319 · see citing works

The p53 family and programmed cell death

Pietsch, E. C., Sykes, S. M., McMahon, S. B., & Murphy, M. E. (2008) · Oncogene · doi:10.1038/onc.2008.315 · Cited by 314 · see citing works

Signal transduction of inflammatory cytokines and tumor development

Yoshimura, A. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00197.x · Cited by 314 · see citing works

The many faces of β-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer

Fuchs, S. Y., Spiegelman, V. S., & Kumar, S. (2004) · Oncogene · doi:10.1038/sj.onc.1207389 · Cited by 311 · see citing works

The p53 family in differentiation and tumorigenesis

Stiewe, T. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2072 · Cited by 306 · see citing works

A phosphorylation-acetylation switch regulates STAT1 signalingPreprint

Krämer, O. H., Knauer, S. K., Greiner, G., Jandt, E., Reichardt, S., Gührs, K., Stauber, R. H., Böhmer, F., & Heinzel, T. (2009) · Genes & Development · doi:10.1101/gad.479209 · Cited by 282 · see citing works

NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy

Shen, H., & Tergaonkar, V. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0315-0 · Cited by 278 · see citing works

Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy

Dick, L. R., & Fleming, P. E. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.01.008 · Cited by 277 · see citing works

Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer

Ramalingam, S. S., Maitland, M. L., Frankel, P. H., Argiris, A. E., Koczywas, M., Gitlitz, B. J., Thomas, S. P., Espinoza‐Delgado, I., Vokes, E. E., Gandara, D. R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.9094 · Cited by 273 · see citing works

Mutant p53: an oncogenic transcription factor

Strano, S., Dell’Orso, S., Agostino, S. D., Fontemaggi, G., Sacchi, A., & Blandino, G. (2007) · Oncogene · doi:10.1038/sj.onc.1210296 · Cited by 270 · see citing works

Mimicking the BH3 domain to kill cancer cells

Chonghaile, T. N., & Letai, A. G. (2008) · Oncogene · doi:10.1038/onc.2009.52 · Cited by 268 · see citing works

Beyond IκBs: alternative regulation of NF‐KB activity

Neumann, M., & Naumann, M. (2007) · The FASEB Journal · doi:10.1096/fj.06-7615rev · Cited by 267 · see citing works

IκB kinase β (IKKβ/IKK2/IKBKB)—A key molecule in signaling to the transcription factor NF-κB

Schmid, J. A., & Birbach, A. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.01.006 · Cited by 260 · see citing works

p53 Induces NF-κB Activation by an IκB Kinase-independent Mechanism Involving Phosphorylation of p65 by Ribosomal S6 Kinase 1

Bohuslav, J., Chen, L., Kwon, H., Mu, Y., & Greene, W. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313509200 · Cited by 256 · see citing works

Multicenter Phase II Trial of YM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non–Small-Cell Lung Cancer

Giaccone, G., Zatloukal, P., Roubec, J., Floor, K., Musil, J., Kůta, M., van Klaveren, R. J., Chaudhary, S., Gunther, A., & Shamsili, S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.1862 · Cited by 247 · see citing works

Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells

Lin, L., Hutzen, B. J., Zuo, M., Ball, S. L., Deangelis, S., Foust, E., Pandit, B., Ihnat, M. A., Shenoy, S. S., Kulp, S. K., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2468 · Cited by 234 · see citing works

A nuclear poly(ADP-Ribose)-dependent signalosome confers DNA damage-induced IκB kinase activation.

Stilmann, M., Hinz, M., Arslan, S. Ç., Zimmer, A., Schreiber, V., & Scheidereit, C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.032 · Cited by 232 · see citing works

PIASy mediates NEMO sumoylation and NF-κB activation in response to genotoxic stress

Mabb, A. M., Wuerzberger‐Davis, S. M., & Miyamoto, S. (2006) · Nature Cell Biology · doi:10.1038/ncb1458 · Cited by 226 · see citing works

Acetylation of Stat1 modulates NF-κB activityPreprint

Krämer, O. H., Baus, D., Knauer, S. K., Stein, S., Jäger, E., Stauber, R. H., Grez, M., Pfitzner, E., & Heinzel, T. (2006) · Genes & Development · doi:10.1101/gad.364306 · Cited by 220 · see citing works

p53-family proteins and their regulators: hubs and spokes in tumor suppression

Collavin, L., Lunardi, A., & Sal, G. D. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.35 · Cited by 219 · see citing works

Phase I Trial of Histone Deacetylase Inhibition by Valproic Acid Followed by the Topoisomerase II Inhibitor Epirubicin in Advanced Solid Tumors: A Clinical and Translational Study

Münster, P. N., Marchion, D. C., Biçaku, E., Schmitt, M. L., Lee, J., DeConti, R. C., Simon, G. R., Fishman, M., Minton, S. E., Garrett, C. R., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.6165 · Cited by 216 · see citing works

Riboflavin kinase couples TNF receptor 1 to NADPH oxidase

Yazdanpanah, B., Wiegmann, K., Tchikov, V., Krut, O., Pongratz, C., Schramm, M., Kleinridders, A., Wunderlich, T., Kashkar, H., Utermöhlen, O., et al. (2009) · Nature · doi:10.1038/nature08206 · Cited by 215 · see citing works

A common gain of function of p53 cancer mutants in inducing genetic instability

Liu, D., Song, H., & Xu, Y. (2009) · Oncogene · doi:10.1038/onc.2009.376 · Cited by 214 · see citing works

Transcription regulation by mutant p53

Weisz, L., Oren, M., & Rotter, V. (2007) · Oncogene · doi:10.1038/sj.onc.1210294 · Cited by 207 · see citing works

How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?

Olsson, A., Manzl, C., Strasser, A., & Villunger, A. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402196 · Cited by 200 · see citing works

Mutant p53 Enhances Nuclear Factor κB Activation by Tumor Necrosis Factor α in Cancer Cells

Weisz, L., Damalas, A., Liontos, M., Karakaidos, P., Fontemaggi, G., Maor-Aloni, R., Kalis, M. L., Levrero, M., Strano, S., Gorgoulis, V. G., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2425 · Cited by 198 · see citing works

Pancreas-specific RelA/p65 truncation increases susceptibility of acini to inflammation-associated cell death following cerulein pancreatitis.

Algül, H., Treiber, M., Lesina, M., Nakhai, H., Saur, D., Geisler, F., Pfeifer, A., Paxian, S. A., & Schmid, R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29882 · Cited by 194 · see citing works

Loss of p53 enhances catalytic activity of IKKβ through O-linked β-N-acetyl glucosamine modification

Kawauchi, K., Araki, K., Tobiume, K., & Tanaka, N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813210106 · Cited by 193 · see citing works

Requirement of the NF-κB Subunit p65/RelA for K-Ras–Induced Lung Tumorigenesis

Bassères, D. S., Ebbs, A., Levantini, E., & Baldwin, A. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4290 · Cited by 189 · see citing works

ATM Is Required for IκB Kinase (IKK) Activation in Response to DNA Double Strand Breaks

Li, N., Banin, S., Ouyang, H., Li, G. C., Courtois, G., Shiloh, Y., Karin, M., & Rotman, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009809200 · Cited by 188 · see citing works

Large-Scale Mutagenesis in p19ARF- and p53-Deficient Mice Identifies Cancer Genes and Their Collaborative Networks

Uren, A. G., Kool, J., Matentzoglu, K., de Ridder, J., Mattison, J., van Uitert, M., Lagcher, W., Sie, D., Tanger, E., Cox, T., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.021 · Cited by 179 · see citing works

p53 and NF‐κB: different strategies for responding to stress lead to a functional antagonism

Ak, P., & Levine, A. J. (2010) · The FASEB Journal · doi:10.1096/fj.10-160549 · Cited by 178 · see citing works

Loss of Epithelial RelA Results in Deregulated Intestinal Proliferative/Apoptotic Homeostasis and Susceptibility to Inflammation

Steinbrecher, K. A., Harmel-Laws, E., Sitcheran, R., & Baldwin, A. S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2588 · Cited by 174 · see citing works

HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IκB and β-catenin

Fuchs, S. Y., Chen, A., Xiong, Y., Pan, Z., & Ronai, Z. A. (1999) · Oncogene · doi:10.1038/sj.onc.1202760 · Cited by 174 · see citing works

Epidermal Growth Factor Receptor and Mutant p53 Expand an Esophageal Cellular Subpopulation Capable of Epithelial-to-Mesenchymal Transition through ZEB Transcription Factors

Ohashi, S., Natsuizaka, M., Wong, G. S., Michaylira, C. Z., Grugan, K. D., Stairs, D. B., Kalabis, J., Vega, M. E., Kalman, R. A., Nakagawa, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4614 · Cited by 164 · see citing works

HDACi – Targets beyond chromatin

Buchwald, M., Krämer, O. H., & Heinzel, T. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.028 · Cited by 160 · see citing works

PUMA is directly activated by NF-κB and contributes to TNF-α-induced apoptosis

Wang, P., Qiu, W., Dudgeon, C., Liu, H., Huang, C., Zambetti, G. P., Yu, J., & Zhang, L. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.51 · Cited by 159 · see citing works

HDAC2: a critical factor in health and disease

Krämer, O. H. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.09.007 · Cited by 157 · see citing works

Autoregulatory feedback loops terminating the NF-κB response

Renner, F., & Schmitz, M. L. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2008.12.003 · Cited by 156 · see citing works

STAT5‐induced Id‐1 transcription involves recruitment of HDAC1 and deacetylation of C/EBPβ

Xu, M. J., Nie, L., Kim, S., & Sun, X. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg094 · Cited by 155 · see citing works

The relative toxicity of nonsteroidal antiinflammatory drugs

Fries, J. F., Williams, C. A., & Bloch, D. A. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780341103 · Cited by 153 · see citing works

Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor α, in response to deacetylase inhibition by valproic acid and trichostatin A

Reid, G., Métivier, R., Lin, C., Denger, S., Ibberson, D., Ivacevic, T., Brand, H., Beneš, V., Liu, E. T., & Gannon, F. (2005) · Oncogene · doi:10.1038/sj.onc.1208662 · Cited by 152 · see citing works

Cross talk between stimulated NF-κB and the tumor suppressor p53

Schneider, G., Henrich, A., Greiner, G., Wolf, V, Lovas, A., Wieczorek, M., Wagner, T., Reichardt, S., von Werder, A., Schmid, R. M., et al. (2010) · Oncogene · doi:10.1038/onc.2010.46 · Cited by 149 · see citing works

Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-κB pathways

Dey, A., Tergaonkar, V., & Lane, D. P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2759 · Cited by 146 · see citing works

Phosphorylation of p53 by IκB kinase 2 promotes its degradation by β-TrCP

Xia, Y., Padre, R. C., de Mendoza, T. H., Bottero, V., Tergaonkar, V., & Verma, I. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812256106 · Cited by 146 · see citing works

Massively regulated genes: the example of TP53

Hollstein, M. C., & Hainaut, P. L. (2009) · The Journal of Pathology · doi:10.1002/path.2637 · Cited by 142 · see citing works

Rescue of mutant p53 transcription function by ellipticine

Peng, Y., Li, C., Chen, L., Sebti, S. M., & Chen, J. (2003) · Oncogene · doi:10.1038/sj.onc.1206777 · Cited by 141 · see citing works

Many faces of NF-κB signaling induced by genotoxic stress

Wu, Z., & Miyamoto, S. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0227-9 · Cited by 129 · see citing works

A pervasive role of ubiquitin conjugation in activation and termination of IκB kinase pathways

Krappmann, D., & Scheidereit, C. (2005) · The EMBO Reports · doi:10.1038/sj.embor.7400380 · Cited by 128 · see citing works

Apoptosis-promoted tumorigenesis: γ-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte deathPreprint

Michalak, E. M., Vandenberg, C. J., Delbridge, A. R. D., Wu, L., Scott, C. L., Adams, J. M., & Strasser, A. (2010) · Genes & Development · doi:10.1101/gad.1940110 · Cited by 127 · see citing works

The Activated NF-κB-Snail-RKIP Circuitry in Cancer Regulates Both the Metastatic Cascade and Resistance to Apoptosis by Cytotoxic Drugs

Wu, K., & Bonavida, B. (2009) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v29.i3.40 · Cited by 126 · see citing works

Linkage between EGFR family receptors and nuclear factor kappaB (NF‐κB) signaling in breast cancer

Biswas, D. K., & Iglehart, J. D. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20785 · Cited by 123 · see citing works

p53 Up-regulated Modulator of Apoptosis (PUMA) Activation Contributes to Pancreatic β-Cell Apoptosis Induced by Proinflammatory Cytokines and Endoplasmic Reticulum Stress

Gurzov, E. N., Germano, C. M. R., Cunha, D. A., Ortis, F., Vanderwinden, J., Marchetti, P., Zhang, L., & Eizirik, D. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.122374 · Cited by 122 · see citing works

Fighting Cancer with Red Wine? Molecular Mechanisms of Resveratrol

Kraft, T. E., Parisotto, D. A., Schempp, C. M., & Efferth, T. (2009) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390802248627 · Cited by 116 · see citing works

Oscillations and bistability in the stochastic model of p53 regulation

Puszyński, K., Hat, B., & Lipniacki, T. (2008) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2008.05.039 · Cited by 112 · see citing works

The Proteasome Inhibitor Bortezomib Acts Independently of p53 and Induces Cell Death via Apoptosis and Mitotic Catastrophe in B-Cell Lymphoma Cell Lines

Strauss, S. J., Higginbottom, K., Jueliger, S., Maharaj, L., Allen, P. D., Schenkein, D. P., Lister, T. A., & Joel, S. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3254 · Cited by 111 · see citing works

Mechanism of processing of the NF-κB2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCFβ-TrCP ubiquitin ligase

Amir, R. E., Haecker, H., Karin, M., & Ciechanover, A. J. (2003) · Oncogene · doi:10.1038/sj.onc.1207366 · Cited by 109 · see citing works

Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formationPreprint

Labi, V., Erlacher, M., Krumschnabel, G., Manzl, C., Tzankov, A., Pinon, J., Egle, A., & Villunger, A. (2010) · Genes & Development · doi:10.1101/gad.1940210 · Cited by 108 · see citing works

A signal network involving coactivated NF‐κB and STAT3 and altered p53 modulates BAX/BCL‐XL expression and promotes cell survival of head and neck squamous cell carcinomas

Lee, T., Yeh, J., Friedman, J., Yan, B., Yang, X., Yeh, N. T., Waes, C. V., & Chen, Z. (2008) · International Journal of Cancer · doi:10.1002/ijc.23324 · Cited by 108 · see citing works

Restoration of p53 to limit tumor growth

Wang, W., & El‐Deiry, W. S. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f31d6f · Cited by 104 · see citing works

Conditional ablation of Ikkb inhibits melanoma tumor development in mice

Yang, J., Splittgerber, R. C., Yull, F. E., Kantrow, S. M., Ayers, G. D., Karin, M., & Richmond, A. J. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42358 · Cited by 101 · see citing works

Posttranslational modifications of NEMO and its partners in NF-κB signaling

Sebban, H., Yamaoka, S., & Courtois, G. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.09.004 · Cited by 100 · see citing works

SUMOylation-Dependent Localization of IKKɛ in PML Nuclear Bodies Is Essential for Protection against DNA-Damage-Triggered Cell Death

Renner, F., Moreno, R., & Schmitz, M. L. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.018 · Cited by 100 · see citing works

Phosphorylation–acetylation switch in the regulation of STAT1 signaling

Krämer, O. H., & Heinzel, T. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.10.007 · Cited by 99 · see citing works

Penta-1,2,3,4,6-O-galloyl-β- d -glucose induces p53 and inhibits STAT3 in prostate cancer cellsin vitroand suppresses prostate xenograft tumor growthin vivo

Hu, H., Lee, H., Jiang, C., Zhang, J., Wang, L., Zhao, Y., Xiang, Q., Lee, E., Kim, S., & Lü, J. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0456 · Cited by 97 · see citing works

Histone Deacetylase Inhibitors Suppress the Inducibility of Nuclear Factor-κB by Tumor Necrosis Factor-α Receptor-1 Down-regulation

Imre, G., Gekeler, V., Leja, A., Beckers, T. L., & Boehm, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4225 · Cited by 96 · see citing works

Mutant p53-induced Up-regulation of Mitogen-activated Protein Kinase Kinase 3 Contributes to Gain of Function

Gurtner, A., Starace, G., Norelli, G., Piaggio, G., Sacchi, A., & Bossi, G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094813 · Cited by 92 · see citing works

Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosis

Krämer, O. H., Knauer, S. K., Zimmermann, D., Stauber, R. H., & Heinzel, T. (2007) · Oncogene · doi:10.1038/sj.onc.1210677 · Cited by 87 · see citing works

Depletion of Mutant p53 and Cytotoxicity of Histone Deacetylase Inhibitors

Blagosklonny, M. V., Trostel, S. Y., Kayastha, G., Demidenko, Z. N., Vassilev, L. T., Romanova, L. Y., Bates, S. E., & Fojo, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3433 · Cited by 83 · see citing works

NF-κB activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage

Wuerzberger‐Davis, S. M., Nakamura, Y., Seufzer, B. J., & Miyamoto, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209815 · Cited by 82 · see citing works

Wild-type p53 in cancer cells: When a guardian turns into a blackguard

Kim, E. L., Giese, A., & Deppert, W. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.08.030 · Cited by 82 · see citing works

Induction of a pro‐apoptotic ATM–NF‐κB pathway and its repression by ATR in response to replication stress

Wu, Z., & Miyamoto, S. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.127 · Cited by 82 · see citing works

Mutant p53 initiates a feedback loop that involves Egr-1/EGF receptor/ERK in prostate cancer cells

Sauer, L., Gitenay, D., Vo, C., & Baron, V. T. (2010) · Oncogene · doi:10.1038/onc.2010.24 · Cited by 81 · see citing works

The value of proteasome inhibition in cancer

Cvek, B., & Dvořák, Z. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.05.003 · Cited by 77 · see citing works

Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway

Dong, P., Xu, Z., Jia, N., Li, D., & Feng, Y. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-103 · Cited by 75 · see citing works

ATM mediates constitutive NF-κB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia

Grosjean-Raillard, J., Tailler, M., Adès, L., Perfettini, J., Fabre, C., Braun, T., de Botton, S., Fenaux, P., & Kroemer, G. (2008) · Oncogene · doi:10.1038/onc.2008.457 · Cited by 74 · see citing works

KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells

Marreiros, A., Dudgeon, K., Dao, V. A., Grimm, M., Czolij, R., Crossley, M., & Jackson, P. (2004) · Oncogene · doi:10.1038/sj.onc.1208216 · Cited by 73 · see citing works

Nutlin-3 inhibits the NFκB Pathway in a p53 Dependent Manner: Implications in Lung Cancer Therapy

Dey, A., Wong, E. T., Bist, P., Tergaonkar, V., & Lane, D. (2007) · Cell Cycle · doi:10.4161/cc.6.17.4643 · Cited by 70 · see citing works

The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells

Trus, M., Yang, L., Suárez, F., Bordeleau, L. J., Jurišica, I., & Minden, M. D. (2005) · Leukemia · doi:10.1038/sj.leu.2403773 · Cited by 70 · see citing works

Regulation of p53: TRIM24 enters the RING

Jain, A. K., & Barton, M. C. (2009) · Cell Cycle · doi:10.4161/cc.8.22.9979 · Cited by 68 · see citing works

Contradictory functions of NF-κB in liver physiology and cancer

Vainer, G. W., Pikarsky, E., & Ben‐Neriah, Y. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.016 · Cited by 67 · see citing works

Activated p53 induces NF-κB DNA binding but suppresses its transcriptional activation

Kawauchi, K., Araki, K., Tobiume, K., & Tanaka, N. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.021 · Cited by 66 · see citing works

α-Bisabolol induces dose- and time-dependent apoptosis in HepG2 cells via a Fas- and mitochondrial-related pathway, involves p53 and NFκB

Chen, W., Hou, J., Yin, Y., Jang, J., Zheng, Z., Fan, H., & Zou, G. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.03.021 · Cited by 64 · see citing works

Crippling p53 activities via knock-in mutations in mouse models

Iwakuma, T., & Lozano, G. (2007) · Oncogene · doi:10.1038/sj.onc.1210278 · Cited by 63 · see citing works

Synergistic Growth Inhibition of Squamous Cell Carcinoma of the Head and Neck by Erlotinib and Epigallocatechin-3-Gallate: The Role of p53-Dependent Inhibition of Nuclear Factor-κB

Amin, A. R. M. R., Khuri, F. R., Chen, Z., & Shin, D. M. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0063 · Cited by 62 · see citing works

Wild-type p53 Inhibits Nuclear Factor-κB–Induced Matrix Metalloproteinase-9 Promoter Activation: Implications for Soft Tissue Sarcoma Growth and Metastasis

Liu, J., Zhan, M., Hannay, J. A. F., Das, P. K., Bolshakov, S. V., Kotilingam, D., Yu, D., Lazar, A. F., Pollock, R. E., & Lev, D. C. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0201 · Cited by 61 · see citing works

Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53

Wang, L., He, G., Zhang, P., Wang, X., Jiang, M. H., & Yu, L. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0099-x · Cited by 60 · see citing works

Cancer cells suppress p53 in adjacent fibroblasts

Bar, J., Feniger-Barish, R., Lukashchuk, N., Shaham, H., Moskovits, N. B.-C., Goldfinger, N., Simansky, D. A., Perlman, M., Papa, M. Z., Yosepovich, A., et al. (2008) · Oncogene · doi:10.1038/onc.2008.445 · Cited by 60 · see citing works

Targeting the Fas/Fas ligand pathway in cancer

O’Brien, D. I., Nally, K., Kelly, R., O’Connor, T. M., Shanahan, F., & O’Connell, J. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.5.1031 · Cited by 55 · see citing works

p53 dominant-negative mutant R273H promotes invasion and migration of human endometrial cancer HHUA cells

Dong, P., Tada, M., Hamada, J., Nakamura, A., Moriuchi, T., & Sakuragi, N. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9084-8 · Cited by 54 · see citing works

The p53 Family Protein p73 Provides New Insights into Cancer Chemosensitivity and Targeting

Lunghi, P., Costanzo, A., Mazzera, L., Rizzoli, V., Levrero, M., & Bonati, A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1229 · Cited by 54 · see citing works

Inhibition of Pancreatic Cancer Cell Growth by Cucurbitacin B Through Modulation of Signal Transducer and Activator of Transcription 3 Signaling

Zhang, M., Sun, C., Shan, X., Yang, X., Li‐Ling, J., & Deng, Y. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ce719e · Cited by 53 · see citing works

p53-Dependent p21-mediated growth arrest pre-empts and protects HCT116 cells from PUMA-mediated apoptosis induced by EGCG

Thakur, V. S., Amin, A. R. M. R., Paul, R. K., Gupta, K., Hastak, K., Agarwal, M. K., Jackson, M. W., Wald, D. N., Mukhtar, H., & Agarwal, M. L. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.04.012 · Cited by 53 · see citing works

Nuclear factor-kappa B links carcinogenic and chemopreventive agents

Aggarwal, B. B. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s6 · Cited by 50 · see citing works

Nuclear Factor κB- and Specificity Protein 1-dependent p53-mediated Bi-directional Regulation of the Human Manganese Superoxide Dismutase Gene

Dhar, S. K., Xu, Y., & Clair, D. K. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.060715 · Cited by 50 · see citing works

ADP‐ribosylation of actins by arginine‐specific ADP‐ribosyltransferase purified from chicken heterophils

Terashima, M., Mishima, K., Yamada, K., Tsuchiya, M., Wakutani, T., & Shimoyama, M. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb16638.x · Cited by 49 · see citing works

Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells.

Gurova, K. V., Rokhlin, O. W., Budanov, A. V., Burdelya, L., Chumakov, P. M., Cohen, M. B., & Gudkov, A. V. (2003) · PubMed · Cited by 49 · see citing works

Reactivation of p53 by Novel MDM2 Inhibitors: Implications for Pancreatic Cancer Therapy

Azmi, A. S., Philip, P. A., Aboukameel, A., Wang, Z., Banerjee, S., Zafar, S. F., Goustin, A. S., Almhanna, K., Yang, D., Sarkar, F. H., et al. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910791190229 · Cited by 42 · see citing works

Immortalized fibroblasts from NF-κB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor α after transformation by v-Ras

Gapuzan, M.-E. R., Schmah, O., Pollock, A. D., Hoffmann, A., & Gilmore, T. D. (2005) · Oncogene · doi:10.1038/sj.onc.1208809 · Cited by 41 · see citing works

Stabilization of p53 and transactivation of its target genes in response to replication blockade

Nayak, B. K., & Das, G. M. (2002) · Oncogene · doi:10.1038/sj.onc.1205889 · Cited by 40 · see citing works

Ubiquitin signals in the NF-κB pathway

Terzić, J., Marinovic‐Terzić, I., Ikeda, F., & Đikić, I. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350942 · Cited by 40 · see citing works

In good times and bad: p73 in cancer

Oswald, C., & Stiewe, T. (2008) · Cell Cycle · doi:10.4161/cc.7.12.6148 · Cited by 39 · see citing works

Defective autophagy control by the p53 rheostat in cancer

Galluzzi, L., Morselli, E., Kepp, O., Maiuri, M. C., & Kroemer, G. (2010) · Cell Cycle · doi:10.4161/cc.9.2.10493 · Cited by 39 · see citing works

Novel Derivative of Benzofuran Induces Cell Death Mostly by G2/M Cell Cycle Arrest through p53-dependent Pathway but Partially by Inhibition of NF-κB

Manna, S. K., Bose, J. S., Gangan, V. D., Raviprakash, N., Navaneetha, T., Raghavendra, P. B., Banaganapalli, B., Kumar, C. S., & Jain, S. K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.131797 · Cited by 38 · see citing works

Preclinical evidence for a beneficial impact of valproate on the response of small cell lung cancer to first-line chemotherapy

Hubaux, R., Vandermeers, F., Crisanti, M. C., Kapoor, V., Burny, A., Mascaux, C., Albelda, S., & Willems, L. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.03.021 · Cited by 38 · see citing works

p53-mediated induction of Noxa and p53AIP1 requires NFκB

O’Prey, J., Crighton, D., Martín, Á. G., Vousden, K. H., Fearnhead, H. O., & Ryan, K. M. (2010) · Cell Cycle · doi:10.4161/cc.9.5.10872 · Cited by 37 · see citing works

Non-genotoxic anti-neoplastic effects of ellipticine derivative NSC176327 in p53-deficient human colon carcinoma cells involve stimulation of p73

Lü, C., Wang, W., & El‐Deiry, W. S. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.12.7461 · Cited by 37 · see citing works

Nuclear factor-kappaB-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53.

Shinohara, T., Miki, T., Nishimura, N., Nokihara, H., Hamada, H., Mukaida, N., & Sone, S. (2001) · PubMed · Cited by 34 · see citing works

The do's and don'ts of p53 isoforms

Jänicke, R. U., Graupner, V., Budach, W., & Eßmann, F. (2009) · Biological Chemistry · doi:10.1515/bc.2009.093 · Cited by 31 · see citing works

HDAC2 deficiency sensitizes colon cancer cells to TNFα-induced apoptosis through inhibition of NF-κB activity

Kaler, P., Sasazuki, T., Shirasawa, S., Augenlicht, L. H., & Klampfer, L. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.01.010 · Cited by 30 · see citing works

Mutant p53 (G199V) Gains Antiapoptotic Function through Signal Transducer and Activator of Transcription 3 in Anaplastic Thyroid Cancer Cells

Kim, T. H., Lee, S. Y., Rho, J. H., Jeong, N. Y., Soung, Y. H., Jo, W. S., Kang, D.-Y., Kim, S.-H., & Yoo, Y. H. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0117 · Cited by 30 · see citing works

Loss of Nuclear Factor-κB Is Tumor Promoting but Does Not Substitute for Loss of p53

Ryan, K. M., O’Prey, J., & Vousden, K. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1474 · Cited by 29 · see citing works

Cell Cycle Regulation of NF-κB-Binding Activity in Cells from Human Glioblastomas

Ansari, S. A., Safak, M., Valle, L. D., Enam, S., Amini, S., & Khalili, K. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5168 · Cited by 28 · see citing works

ARF the Integrator: Linking NF-?B, p53 and Checkpoint Kinases

Rocha, S., & Perkins, N. D. (2005) · Cell Cycle · doi:10.4161/cc.4.6.1739 · Cited by 26 · see citing works

Dynamics of estrogen receptor-mediated transcriptional activation of responsive genes in vivo: apprehending transcription in four dimensions.

Métivier, R., Huet, G., Gallais, R., Finot, L., Petit, F., Tiffoche, C., Mérot, Y., LePéron, C., Reid, G., Penot, G., et al. (2008) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-69080-3_12 · Cited by 21 · see citing works

The peptide‐semicarbazone S‐2209, a representative of a new class of proteasome inhibitors, induces apoptosis and cell growth arrest in multiple myeloma cells

Baumann, P., Müller, K., Mandl–Weber, S., Leban, J. J., Doblhofer, R., Ammendola, A., Baumgartner, R., Oduncu, F. S., & Schmidmaier, R. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07570.x · Cited by 15 · see citing works

Gene expression profile in a glioma cell line resistant to cell death induced by a the chimeric tumor suppressor-1 (CTS-1), a dominant-positive variant of p53—the role of NFκB

Seznec, J., Weit, S., & Naumann, U. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp319 · Cited by 15 · see citing works

Tumor Necrosis Factor α Induces p53 Up-regulated Modulator of Apoptosis Expression in Colorectal Cancer Cell Lines

Pastor, D. M., Irby, R., & Poritz, L. S. (2010) · Diseases of the Colon & Rectum · doi:10.1007/dcr.0b013e3181c522c7 · Cited by 15 · see citing works

Helpers of the cellular gatekeeper—miRNAs dance in P53 network

Shi, M., Liu, D., Shen, B., & Guo, N. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.12.001 · Cited by 13 · see citing works

Interfering with the Dynamics of Estrogen Receptor-Regulated Transcription

Johnsen, S. A., Kangaspeska, S., Reid, G., & Gannon, F. (2007) · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · doi:10.1007/2789_2006_013 · Cited by 9 · see citing works

The diverse and complex roles of NF-κB subunits in cancer

Perkins, N. D. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3204 · Cited by 845 · see citing works

Targeting the NFκB Signaling Pathways for Breast Cancer Prevention and Therapy

Wang, W., Nag, S. A., & Zhang, R. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666141106124315 · Cited by 280 · see citing works

Regulation of cell death and autophagy by IKK and NF‐κB: critical mechanisms in immune function and cancer

Baldwin, A. S. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01095.x · Cited by 277 · see citing works

Inflammation and p53: A Tale of Two Stresses

Gudkov, A. V., Gurova, K. V., & Komarova, E. A. (2011) · Genes & Cancer · doi:10.1177/1947601911409747 · Cited by 204 · see citing works

p53 and NF-κB Coregulate Proinflammatory Gene Responses in Human Macrophages

Lowe, J. M., Menéndez, D., Bushel, P. R., Shatz, M., Kirk, E. L., Troester, M. A., Garantziotis, S., Fessler, M. B., & Resnick, M. A. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1070 · Cited by 170 · see citing works

Nrf2 Upregulates ATP Binding Cassette Transporter Expression and Activity at the Blood-Brain and Blood-Spinal Cord Barriers

Wang, X., Campos, C. R., Peart, J. C., Smith, L. K., Boni, J. L., Cannon, R. E., & Miller, D. S. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2935-13.2014 · Cited by 164 · see citing works

Anti-cancer effects of polyphenols via targeting p53 signaling pathway: updates and future directions

Khan, H. Z., Reale, M., Ullah, H., Sureda, A., Tejada, S., Wang, Y., Zhang, Z., & Xiao, J. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.04.007 · Cited by 157 · see citing works

Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy

Cahill, K. E., Morshed, R. A., & Yamini, B. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov265 · Cited by 142 · see citing works

Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKα/IKKβ

Jin, S., Mutvei, A. P., Chivukula, I. V., Andersson, E. R., Ramsköld, D., Sandberg, R., Lee, K. L., Kronqvist, P., Mamaeva, V., Östling, P., et al. (2012) · Oncogene · doi:10.1038/onc.2012.517 · Cited by 141 · see citing works

Survivin and YM155: How faithful is the liaison?

Rauch, A., Hennig, D., Schäfer, C., Wirth, M., Marx, C., Heinzel, T., Schneider, G., & Krämer, O. H. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.01.003 · Cited by 131 · see citing works

Oxidative stress-induced skeletal muscle injury involves in NF-κB/p53-activated immunosuppression and apoptosis response in copper (II) or/and arsenite-exposed chicken

Zhao, H., Wang, Y., Shao, Y., Liu, J., Wang, S., & Xing, M. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.06.165 · Cited by 127 · see citing works

NF-κB Signalling in Glioblastoma

Soubannier, V., & Stifani, S. (2017) · Biomedicines · doi:10.3390/biomedicines5020029 · Cited by 120 · see citing works

p53 and the Carcinogenicity of Chronic InflammationPreprint

Gudkov, A. V., & Komarova, E. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026161 · Cited by 122 · see citing works

HDAC1 and HDAC2 integrate the expression of p53 mutants in pancreatic cancer

Stojanovic, N., Hassan, Z., Wirth, M., Wenzel, P., Beyer, M., Schäfer, C., Brand, P., Kroemer, A., Stauber, R. H., Schmid, R. M., et al. (2016) · Oncogene · doi:10.1038/onc.2016.344 · Cited by 106 · see citing works

Regulation of p53 and Rb Links the Alternative NF-κB Pathway to EZH2 Expression and Cell Senescence

Iannetti, A., Ledoux, A., Tudhope, S. J., Sellier, H., Zhao, B., Mowla, S. N., Moore, A., Hummerich, H., Gewurz, B. E., Cockell, S., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004642 · Cited by 105 · see citing works

Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma

Voce, D. J., Bernal, G. M., Wu, L., Crawley, C. D., Zhang, W., Mansour, N. M., Cahill, K. E., Szymura, S. J., Uppal, A., Raleigh, D. R., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2170 · Cited by 92 · see citing works

NF-κB in colorectal cancer

Vaiopoulos, G., Athanasoula, K. C., & Papavassiliou, A. G. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1045-x · Cited by 91 · see citing works

Acetylation modulates the STAT signaling code

Wieczorek, M., Ginter, T., Brand, P., Heinzel, T., & Krämer, O. H. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.06.005 · Cited by 89 · see citing works

p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors

Sonnemann, J., Marx, C., Becker, S., Wittig, S., Palani, C. D., Krämer, O. H., & Beck, J. F. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.742 · Cited by 85 · see citing works

Histone deacetylase 2 controls p53 and is a critical factor in tumorigenesis

Wagner, T., Brand, P., Heinzel, T., & Krämer, O. H. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.07.010 · Cited by 84 · see citing works

Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress

Brandl, A., Wagner, T., Uhlig, K. M., Knauer, S. K., Stauber, R. H., Melchior, F., Schneider, G., Heinzel, T., & Krämer, O. H. (2012) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjs013 · Cited by 81 · see citing works

A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer

Stauber, R. H., Knauer, S. K., Habtemichael, N., Bier, C., Unruhe, B., Weisheit, S., Spange, S., Nonnenmacher, F., Fetz, V., Ginter, T., et al. (2011) · Oncotarget · doi:10.18632/oncotarget.430 · Cited by 68 · see citing works

Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer

da Silva, H. B., Amaral, E. P., Nolasco, E. L., de Victo, N. C., Atique, R., Jank, C. C., Anschau, V., Zerbini, L. F., & Correa, R. G. (2013) · Prostate Cancer · doi:10.1155/2013/920612 · Cited by 69 · see citing works

The Bad, the Good, and the Ugly about Oxidative Stress

Jiménez-Del-Río, M., & Velez‐Pardo, C. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/163913 · Cited by 64 · see citing works

Urolithin A gains in antiproliferative capacity by reducing the glycolytic potential via the p53/TIGAR axis in colon cancer cells

Norden, E., & Heiß, E. H. (2018) · Carcinogenesis · doi:10.1093/carcin/bgy158 · Cited by 59 · see citing works

Another Look at Dietary Polyphenols: Challenges in Cancer Prevention and Treatment

Arrigoni, R., Ballini, A., Santacroce, L., Cantore, S., Inchingolo, A. M., Inchingolo, F., Domenico, M. D., Quagliuolo, L., & Boccellino, M. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210810154732 · Cited by 56 · see citing works

The Inhibitory Effect of Intravesical Fisetin against Bladder Cancer by Induction of p53 and Down‐Regulation of NF ‐kappa B Pathways in a Rat Bladder Carcinogenesis Model

Li, J., Qu, W., Cheng, Y., Sun, Y., Jiang, Y., Zou, T., Wang, Z., Xu, Y., & Zhao, H. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12229 · Cited by 54 · see citing works

Quercetin in Cancer Prevention and Therapy

Chirumbolo, S. (2012) · Integrative Cancer Therapies · doi:10.1177/1534735412448215 · Cited by 54 · see citing works

Cinnamaldehyde protects against rat intestinal ischemia/reperfusion injuries by synergistic inhibition of NF-κB and p53

Almoiliqy, M., Wen, J., Xu, B., Sun, Y., Lian, M., Li, Y., Qaed, E., AL-Azab, M. A., Chen, D., Shopit, A., et al. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0359-9 · Cited by 54 · see citing works

Cell plasticity modulation by flavonoids in resistant breast carcinoma targeting the nuclear factor kappa B signaling

Kubatka, P., Koklesová, L., Mazuráková, A., Brockmueller, A., Büsselberg, D., Kello, M., & Shakibaei, M. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-023-10134-x · Cited by 52 · see citing works

Antitumor effects of traditional Chinese medicine targeting the cellular apoptotic pathway

Lin, X., Xu, H., Zhao, X., Liu, X., Zhang, K., & Xu, P. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s80902 · Cited by 54 · see citing works

Sumoylation of HDAC2 promotes NF-κB-dependent gene expression

Wagner, T., Kiweler, N., Wolff, K., Knauer, S. K., Brandl, A., Hemmerich, P. H., Dannenberg, J., Heinzel, T., Schneider, G., & Krämer, O. H. (2015) · Oncotarget · doi:10.18632/oncotarget.3344 · Cited by 46 · see citing works

Class I histone deacetylases regulate p53/NF-κB crosstalk in cancer cells

Schäfer, C., Göder, A., Beyer, M., Kiweler, N., Mahendrarajah, N., Rauch, A., Nikolova, T., Stojanovic, N., Wieczorek, M., Reich, T. R., et al. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.11.002 · Cited by 46 · see citing works

αB-crystallin regulates oxidative stress-induced apoptosis in cardiac H9c2 cells via the PI3K/AKT pathway

Xu, F. H., Yu, H., Liu, J., & Cheng, L. Y. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2332-2 · Cited by 43 · see citing works

The biology of interleukin-1: emerging concepts in the regulation of the actin cytoskeleton and cell junction dynamics

Lie, P. P. Y., Cheng, C. Y., & Mruk, D. D. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0760-0 · Cited by 40 · see citing works

Unraveling Regulatory Programs for NF-kappaB, p53 and MicroRNAs in Head and Neck Squamous Cell Carcinoma

Yan, B., Li, H., Yang, X., Shao, J., Jang, M., Guan, D., Zou, S., Waes, C. V., Chen, Z., & Zhan, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073656 · Cited by 39 · see citing works

Dexamethasone Reduces Sensitivity to Cisplatin by Blunting p53-Dependent Cellular Senescence in Non-Small Cell Lung Cancer

Ge, H., Ni, S., Wang, X., Xu, N., Liu, Y. M., Wang, X., Wang, L., Song, D., Song, Y., & Bai, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051821 · Cited by 40 · see citing works

Andrographolide Suppresses the Growth and Metastasis of Luminal-Like Breast Cancer by Inhibiting the NF-κB/miR-21-5p/PDCD4 Signaling Pathway

Li, J., Huang, L., He, Z., Chen, M., Ding, Y., Yao, Y., Duan, Y., Li, Z., Qi, C., Zheng, L., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.643525 · Cited by 39 · see citing works

A comparative study of UV-induced cell signalling pathways in human keratinocyte-derived cell lines

Muthusamy, V., & Piva, T. J. (2013) · Archives of Dermatological Research · doi:10.1007/s00403-013-1412-z · Cited by 37 · see citing works

Elevated serine protease HtrA1 inhibits cell proliferation, reduces invasion, and induces apoptosis in esophageal squamous cell carcinoma by blocking the nuclear factor-κB signaling pathway

Xia, J., Wang, F., Wang, L., & Fan, Q. (2012) · Tumor Biology · doi:10.1007/s13277-012-0553-6 · Cited by 34 · see citing works

Targeting cellular apoptotic pathway with peptides from marine organisms

Zheng, L., Lin, X., Wu, N., Liu, M., Zheng, Y., Sheng, J., Ji, X., & Sun, M. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.02.006 · Cited by 32 · see citing works

A Compensatory Role of NF-κB to p53 in Response to 5-FU–Based Chemotherapy for Gastric Cancer Cell Lines

Endo, F., Nishizuka, S., Kume, K., Ishida, K., Katagiri, H., Ishida, K., Sato, K. A., Iwaya, T., Koeda, K., & Wakabayashi, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090155 · Cited by 32 · see citing works

Mdm2 inhibitors synergize with topoisomerase II inhibitors to induce p53-independent pancreatic cancer cell death

Conradt, L., Henrich, A., Wirth, M., Reichert, M., Lesina, M., Algül, H., Schmid, R. M., Krämer, O. H., Saur, D., & Schneider, G. (2013) · International Journal of Cancer · doi:10.1002/ijc.27916 · Cited by 30 · see citing works

Transcriptional regulation of microRNA-100, −146a, and −150 genes by p53 and NFκB p65/RelA in mouse striatal STHdhQ7/ HdhQ7cells and human cervical carcinoma HeLa cells

Ghose, J., & Bhattacharyya, N. P. (2015) · RNA Biology · doi:10.1080/15476286.2015.1014288 · Cited by 28 · see citing works

Quercetin: A Promising Flavonoid with a Dynamic Ability to Treat Various Diseases, Infections, and Cancers

Smith, A., Oertle, J. C., III, Warren, D., & Prato, D. (2016) · Journal of Cancer Therapy · doi:10.4236/jct.2016.72010 · Cited by 29 · see citing works

Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells

Rauch, A., Carlstedt, A., Emmerich, C., Mustafa, A. M., Göder, A., Knauer, S. K., Linnebacher, M., Heinzel, T., & Krämer, O. H. (2018) · Oncotarget · doi:10.18632/oncotarget.25600 · Cited by 29 · see citing works

Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression

Remels, A. H. V., Gosker, H. R., LANGEN, R. C. J., Polkey, M. I., Sliwinski, P., Gáldiz, J. B., van den Borst, B., Pansters, N., & Schols, A. M. W. J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.11.001 · Cited by 28 · see citing works

FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53

Xu, M., Zhu, J., Liu, S., Wang, C., Shi, Q., Kuang, Y., Fang, X., & Hu, X. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz198 · Cited by 27 · see citing works

Expression of Fbxo7 in Haematopoietic Progenitor Cells Cooperates with p53 Loss to Promote Lymphomagenesis

Lomonosov, M., Meziane, E. K., Ye, H., Nelson, D. E., Randle, S. J., & Laman, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021165 · Cited by 27 · see citing works

Oxidative damage under As3+ and/or Cu2+ stress leads to apoptosis and autophagy and may be cross-talking with mitochondrial disorders in bursa of Fabricius.

Guo, M., Wang, Y., Zhao, H.-J., Mu, M.-Y., Yang, X., Fei, D., Liu, Y., Zong, H., & Xing, M. (2020) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.110989 · Cited by 24 · see citing works

A novel mechanism for inhibition of lipopolysaccharide-induced proinflammatory cytokine production by valproic acid

Jambalganiin, U., Tsolmongyn, B., Koide, N., Odkhuu, E., Naiki, Y., Komatsu, T., Yoshida, T., & Yokochi, T. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.02.032 · Cited by 23 · see citing works

Natural Products as Cytotoxic Agents in Chemotherapy against Cancer

Zyad, A., Leouifoudi, I., Tilaoui, M., Mouse, H. A., Khouchani, M., & Jaafari, A. (2018) · InTech eBooks · doi:10.5772/intechopen.72744 · Cited by 21 · see citing works

Potential Regulation Mechanisms of P-gp in the Blood-Brain Barrier in Hypoxia

Ding, Y., Wang, R., Zhang, J., Zhao, A., Lu, H., Li, W., Wang, C., & Yuan, X. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190610140153 · Cited by 20 · see citing works

Lipopolysaccharide prevents valproic acid-induced apoptosis via activation of nuclear factor-κB and inhibition of p53 activation

Tsolmongyn, B., Koide, N., Odkhuu, E., Haque, A., Naiki, Y., Komatsu, T., Yoshida, T., & Yokochi, T. (2013) · Cellular Immunology · doi:10.1016/j.cellimm.2013.04.011 · Cited by 19 · see citing works

Golgi-SNARE GS28 potentiates cisplatin-induced apoptosis by forming GS28–MDM2–p53 complexes and by preventing the ubiquitination and degradation of p53

Sun, N., Huang, S., Chien, K., & Chao, C. C. ‐. (2012) · Biochemical Journal · doi:10.1042/bj20112223 · Cited by 19 · see citing works

Tumor Protein p63/Nuclear Factor κB Feedback Loop in Regulation of Cell Death

Sen, T., Sen, N., Huang, Y., Sinha, D., Luo, Z., Ratovitski, E. A., & Sidransky, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.257105 · Cited by 18 · see citing works

NKX2-1-mediated p53 expression modulates lung adenocarcinoma progression via modulating IKKβ/NF-κB activation

Chen, P.-M., Wu, T., Cheng, Y., Chen, C., & Lee, H. (2015) · Oncotarget · doi:10.18632/oncotarget.3695 · Cited by 18 · see citing works

Loss of Wilms tumor 1 protein is a marker for apoptosis in response to replicative stress in leukemic cells

Pons, M., Reichardt, C. M., Hennig, D., Nathan, A., Kiweler, N., Stocking, C., Wichmann, C. W., Christmann, M., Butter, F., Reichardt, S., et al. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2202-3 · Cited by 18 · see citing works

Caffeic acid phenethyl ester (CAPE): pharmacodynamics and potential for therapeutic application

Yordanov, Y. (2019) · Pharmacia · doi:10.3897/pharmacia.66.e38573 · Cited by 17 · see citing works

Human Oncoprotein MDM2 Up-regulates Expression of NF- B2 Precursor p100 Conferring a Survival Advantage to Lung Cells

Vaughan, C. A., Mohanraj, L., Singh, S. K., Dumur, C. I., Ramamoorthy, M., Garrett, C. T., Windle, B. E., Yeudall, W. A., Deb, S., & Deb, S. P. (2011) · Genes & Cancer · doi:10.1177/1947601911436008 · Cited by 15 · see citing works

p53 modulates NF-κB mediated epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma

Lin, Y., Clair, J. M., Luo, J., Sharma, S. P., Dubinett, S. M., & John, M. A. S. (2015) · Oral Oncology · doi:10.1016/j.oraloncology.2015.07.006 · Cited by 15 · see citing works

Interaction of NF-κB and FOSL1 drives glioma stemness

Ramar, V., Guo, S., Hudson, B., Khedri, A., Guo, A. A., Li, J., & Liu, M. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05293-1 · Cited by 14 · see citing works

Anti-survivin effect of the small molecule inhibitor YM155 in RCC cells is mediated by time-dependent inhibition of the NF-κB pathway

Sim, M. Y., Yuen, J. S. P., & Go, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-28213-3 · Cited by 14 · see citing works

Effects of fish oil on ethanol-induced gastric ulcer in rats: inflammatory responses and oxidative stress

Mirghaed, M. T., Ghasemian, S. O., Nasab, S. F. M., & Rahimi, K. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001550 · Cited by 13 · see citing works

Transcriptional consequences of impaired immune cell responses induced by cystic fibrosis plasma characterized via dual RNA sequencing

Ideozu, J. E., Rangaraj, V. R., Abdala‐Valencia, H., Zhang, X., Kandpal, M., Sala, M. A., Davuluri, R. V., & Levy, H. (2019) · BMC Medical Genomics · doi:10.1186/s12920-019-0529-0 · Cited by 13 · see citing works

Class 1 Histone Deacetylases and Ataxia-Telangiectasia Mutated Kinase Control the Survival of Murine Pancreatic Cancer Cells upon dNTP Depletion

Nguyen, A., Dzulko, M., Murr, J., Yun, Y., Schneider, G., & Krämer, O. (2021) · Cells · doi:10.3390/cells10102520 · Cited by 10 · see citing works

Mechanisms of p53 Functional De-Regulation: Role of the IκB-α/p53 Complex

Carrà, G., Crivellaro, S., Taulli, R., Guerrasio, A., Saglio, G. N., & Morotti, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17121997 · Cited by 14 · see citing works

Altered Adhesion and Migration of Human Mesenchymal Stromal Cells under Febrile Temperature Stress Involves NF-κβ Pathway

Sen, A., & Ta, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-61361-z · Cited by 13 · see citing works

Dioxonaphthoimidazoliums AB1 and YM155 disrupt phosphorylation of p50 in the NF-κB pathway

Ho, S. S., Ali, A., Chin, T. M., & Go, M. (2016) · Oncotarget · doi:10.18632/oncotarget.7299 · Cited by 12 · see citing works

A new inflammatory role for p53 in human macrophages

Lowe, J. M., Menéndez, D., & Fessler, M. B. (2014) · Cell Cycle · doi:10.4161/15384101.2014.959852 · Cited by 11 · see citing works

TRIM25, TRIM28 and TRIM59 and Their Protein Partners in Cancer Signaling Crosstalk: Potential Novel Therapeutic Targets for Cancer

Chiang, D. C., & Yap, B. K. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46100638 · Cited by 10 · see citing works

Network pharmacology to investigate the pharmacological mechanisms of muscone in Xingnaojing injections for the treatment of severe traumatic brain injury

Liu, Z., Li, H., Ma, W., & Pan, S. (2021) · PeerJ · doi:10.7717/peerj.11696 · Cited by 8 · see citing works

Multiomics plasma effects of switching from triple antiretroviral regimens to dolutegravir plus lamivudine

de Lazzari, E., Negredo, E., Domingo, P., Tiraboschi, J. M., Ribera, E., Abdulghani, N., Alba, V., Fernández‐Arroyo, S., Viladés, C., Peraire, J., et al. (2024) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkae083 · Cited by 6 · see citing works

P53 gene: major mutations in neoplasias and anticancer gene therapy

Lima, C. R. D. O., Rabelo, R. E., Vulcani, V. A. S., Cardoso, L. D., Sousa, N. L. D. M., & de Moura, V. M. B. D. (2012) · Ciência Rural · doi:10.1590/s0103-84782012000500014 · Cited by 6 · see citing works

Synergistic effect of MDM2 inhibitors and radiotherapy in endometrial cancer

Vargas, R., Petty, A. P., Lindner, D. J., Parker, Y., Yard, B. D., Durmaz, A., Lin‐Rahardja, K., Reizes, O., Debernardo, R., & Scott, J. G. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-01063-9 · Cited by 4 · see citing works

Oscillation Expression of NF-$\kappa$ B Driven by Transcription and Translation Time Delays

Liu, L., Yan, F., & Liu, H. (2019) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2019.2946336 · Cited by 4 · see citing works

Identification and characterisation of pro-metastatic targets, pathways and molecular complexes using a toolbox of proteomic technologies.

Faktor, J., Dvořáková, M., Maryáš, J., Struhárová, I., & Bouchal, P. (2012) · PubMed · Cited by 4 · see citing works

Correlation of Before and After Invasive Breast Cancer Neoadjuvant Chemotherapy for NFkB, Cyclin D1, and Survivin Expression

Rustamadji, P., Wiyarta, E., & Anggreani, I. (2023) · Iranian journal of pathology · doi:10.30699/ijp.2023.562935.2983 · Cited by 3 · see citing works

A Review on Picrosides Targeting NFκB and its Proteins for Treatment of Breast Cancer

Soni, D., Anjum, Z., Raza, K., & Verma, S. M. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01281-1 · Cited by 3 · see citing works

First Insight into the Modulation of Noncanonical NF-κB Signaling Components by Poxviruses in Established Immune-Derived Cell Lines: An In Vitro Model of Ectromelia Virus Infection

Struzik, J., Szulc‐Dąbrowska, L., Mielcarska, M. B., Bossowska-Nowicka, M., Koper, M., & Gieryńska, M. M. (2020) · Pathogens · doi:10.3390/pathogens9100814 · Cited by 2 · see citing works

Eupatorium lindleyanum DC. sesquiterpene fraction F1012-2 regulates p53/NF-κB signaling pathways in human breast cancer

Wang, X., Xu, J., Tao, Y., Fan, X., Shen, X., & Tian, S. (2022) · Archives of Biological Sciences · doi:10.2298/abs220630028w · Cited by 1 · see citing works

Protective Effect of Quercetin, Luteolin, and Fisetin via Stimulating the p53-Mediated Signaling in Cancer

Islam, J. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_20 · Cited by 1 · see citing works

Leveraging the p53 signaling pathway as a radio-sensitization strategy in endometrial cancerPreprint

Vargas, R., Petty, A. P., Yard, B. D., Durmaz, A., Lin‐Rahardja, K., Reizes, O., Debernardo, R., & Scott, J. G. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.06.505009 · Cited by 1 · see citing works

Diversifying and Specifying Palliative Care for Patients with Metastatic Cancer by Therapeutic Implementation of Non-Normative Boundary Conditions

Reichle, A., & Hildebrandt, G. C. (2013) · Springer eBooks · doi:10.1007/978-94-007-6866-6_20

Protective Effect of Quercetin, Luteolin, and Fisetin via Stimulating the p53-Mediated Signaling in Cancer

Islam, J. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_20-1

Flavonoids as an Alternative Option to Treat Cancer

Arora, S., Srivastava, S., Verma, U., Sheoran, S., & Kumar, N. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_482

Characterization of protein-protein interactions mediated by the IKK complex

Moro, S. (2022) · theses.fr (ABES) · doi:10.70675/340a028ezd105z4e02z83b4z27f3cd5ea5eb

The complexity of NF-κB signaling in inflammation and cancer

Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,194 · see citing works

P53 vs NF-κB: the role of nuclear factor-kappa B in the regulation of p53 activity and vice versa

Carrà, G., Lingua, M. F., Maffeo, B., Taulli, R., & Morotti, A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03524-9 · Cited by 109 · see citing works

Transcriptional Cross Talk between NF-kB and p53

Biol, M. C., Webster, G. A., Perkins, N. D., Webster, G. A., Neil, & Perkins, D. (1999)

p53 and NFκB： fresh breath in the cross talk

Vinay, & Tergaonkar (2009) · Cited by 1 · see citing works

Cross talk between stimulated NF-κB and the tumor suppressor p53

Schneider, G., Henrich, A., Greiner, G., Wolf, V, Lovas, A., Wieczorek, M., Wagner, T., Reichardt, S., von Werder, A., Schmid, R. M., et al. (2010) · Oncogene · doi:10.1038/onc.2010.46 · Cited by 149 · see citing works